Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

NCT01137630 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Seborrhoeic Dermatitis of the Scalp

Interventions

DRUG: K40a
DRUG: K40b
DRUG: Placebo

Sponsor

Moberg Pharma AB